Back to Search Start Over

Adjuvant Use of Ribavirin with Treatment of Hepatitis C Virus in Kidney Transplant Recipients: A Systematic Review and Meta‑Analysis of Real‑World Data.

Authors :
Bashir, Aamir
Verma, Ashish
Duseja, Ajay
De, Arka
Tiwar, Pramil
Source :
Indian Journal of Transplantation; Jul-Sep2022, Vol. 16 Issue 3, p243-266, 24p
Publication Year :
2022

Abstract

Hepatitis C virus infection among kidney transplant recipients (KTRs) is an important public health concern worldwide. Evidence on available treatments given shows a greater variability for safety and efficacy, thus we performed this large analysis to present the pooled findings. PubMed/Medline, ScienceDirect, and Google Scholar were searched to identify observational studies of both interferon‑based conventional treatment (CT) and recently approved direct‑acting antivirals (DAAs), published before November 2020. Meta‑analysis of effectiveness outcome (sustained virological response [SVR12]) and safety data (adverse events and discontinuation rate) was performed using a random‑effect model. Subgroup analysis based on ± ribavirin with both treatments was performed to assess its relevance in clinical practice. Chi‑square and I2 tests were used to assess heterogeneity between the studies. Twenty‑five and 9 observational records reporting on treatment with DAAs (n = 943) and CT (n = 125), respectively, are analyzed. The overall pooled estimate of SVR12 rate was found as 95.3%, (range: 92.6%–97%) with DAAs in comparison to 46.4% (range: 33.7%–59.6%) with CT. The pooled prevalence of adverse drug reactions (ADRs) in CT was higher as 47.8% than in DAAs as 23.8%, consequently showing a high discontinuation rate of 31.7% in CT as compared to 6.5% with DAAs. Subgroup analyses of both DAAs and interferon‑based treatment ± ribavirin showed decreased effectiveness and increased ADR rates on adding ribavirin. The effectiveness of DDAs was found significantly higher than CT with a better safety profile in KTRs. Ribavirin did not provide any additional benefits while given in combination with either of the treatments available. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22120017
Volume :
16
Issue :
3
Database :
Supplemental Index
Journal :
Indian Journal of Transplantation
Publication Type :
Academic Journal
Accession number :
159482702
Full Text :
https://doi.org/10.4103/ijot.ijot_10_22